Pyroptosis-Mediated Molecular Subtypes and Tumor Microenvironment Infiltration Characterization in Colon Cancer

被引:11
作者
Rao, Jiawei [1 ,2 ]
Li, Wen [2 ]
Chen, Chuangqi [1 ]
机构
[1] Sun Yat Sen Univ, Dept Colorectal Surg, Gastrointestinal Surg Ctr, Affiliated Hosp 1, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Surg Lab, Affiliated Hosp 1, Guangzhou, Peoples R China
关键词
pyroptosis; colon cancer; tumor microenvironment; prognosis; therapy; COLORECTAL-CANCER; THERAPY; HETEROGENEITY; RESISTANCE;
D O I
10.3389/fcell.2021.766503
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The role of pyroptosis, which is also a kind of cell-intrinsic death mechanism, in tumorigenesis and cancer progression has been revolutionized. However, the expression of pyroptosis-related genes (PYGs) in colon cancer (CC) and their prognostic value remain unclear. In this study, we comprehensively identified two PYG-mediated molecular subtypes with a distinct tumor microenvironment (TME) in 1,415 CC samples, which were based on 10 PYGs. The six-gene signature (pyroptosis score, PY-score) was constructed to quantify the molecular patterns of individual tumors using a least absolute shrinkage and selection operator (LASSO)-Cox regression model through the differentially expressed genes between the two molecular subtypes. Significant infiltration of activated immune cells (such as M1 macrophages and cytotoxic T cells) was observed in the low PY-score group, while naive and suppressive immune cells (such as naive CD8(+) T cells and M2 macrophages) dominated in the high PY-score group. CC patients in the low PY-score group showed not only significant survival advantage but also sensitivity to immune checkpoint inhibitor treatment, anti-epidermal growth factor receptor (EGFR) therapy, and chemotherapy. Overall, this work revealed that the PYGs played a vital role in the formation of heterogeneity in the TME. The analysis of the PYG-mediated molecular patterns helps in understanding the characterization of TME infiltration and provides insights into more effective therapeutic strategies.
引用
收藏
页数:13
相关论文
共 39 条
[1]   Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade [J].
Charoentong, Pornpimol ;
Finotello, Francesca ;
Angelova, Mihaela ;
Mayer, Clemens ;
Efremova, Mirjana ;
Rieder, Dietmar ;
Hackl, Hubert ;
Trajanoski, Zlatko .
CELL REPORTS, 2017, 18 (01) :248-262
[2]   TGFβ biology in cancer progression and immunotherapy [J].
Derynck, Rik ;
Turley, Shannon J. ;
Akhurst, Rosemary J. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (01) :9-34
[3]   The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study [J].
Eriksen, Ann Christina ;
Sorensen, Flemming B. ;
Lindebjerg, Jan ;
Hager, Henrik ;
Christensen, Ren dePont ;
Kjaer-Frifeldt, Sanne ;
Hansen, Torben F. .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2018, 33 (08) :1115-1124
[4]   Epigenetics-Based Tumor Cells Pyroptosis for Enhancing the Immunological Effect of Chemotherapeutic Nanocarriers [J].
Fan, Jin-Xuan ;
Deng, Rong-Hui ;
Wang, He ;
Liu, Xin-Hua ;
Wang, Xia-Nan ;
Qin, Ran ;
Jin, Xin ;
Lei, Tian-Run ;
Zheng, Diwei ;
Zhou, Pang-Hu ;
Sun, Yunxia ;
Zhang, Xian-Zheng .
NANO LETTERS, 2019, 19 (11) :8049-8058
[5]   Tumor-associated Macrophages as Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer [J].
Feng, Qingyang ;
Chang, Wenju ;
Mao, Yihao ;
He, Guodong ;
Zheng, Peng ;
Tang, Wentao ;
Wei, Ye ;
Ren, Li ;
Zhu, Dexiang ;
Ji, Meiling ;
Tu, Yongjiu ;
Qin, Xinyu ;
Xu, Jianmin .
CLINICAL CANCER RESEARCH, 2019, 25 (13) :3896-3907
[6]   Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 [J].
Galluzzi, Lorenzo ;
Vitale, Ilio ;
Aaronson, Stuart A. ;
Abrams, John M. ;
Adam, Dieter ;
Agostinis, Patrizia ;
Alnemri, Emad S. ;
Altucci, Lucia ;
Amelio, Ivano ;
Andrews, David W. ;
Annicchiarico-Petruzzelli, Margherita ;
Antonov, Alexey V. ;
Arama, Eli ;
Baehrecke, Eric H. ;
Barlev, Nickolai A. ;
Bazan, Nicolas G. ;
Bernassola, Francesca ;
Bertrand, Mathieu J. M. ;
Bianchi, Katiuscia ;
Blagosklonny, Mikhail V. ;
Blomgren, Klas ;
Borner, Christoph ;
Boya, Patricia ;
Brenner, Catherine ;
Campanella, Michelangelo ;
Candi, Eleonora ;
Carmona-Gutierrez, Didac ;
Cecconi, Francesco ;
Chan, Francis K. -M. ;
Chandel, Navdeep S. ;
Cheng, Emily H. ;
Chipuk, Jerry E. ;
Cidlowski, John A. ;
Ciechanover, Aaron ;
Cohen, Gerald M. ;
Conrad, Marcus ;
Cubillos-Ruiz, Juan R. ;
Czabotar, Peter E. ;
D'Angiolella, Vincenzo ;
Dawson, Ted M. ;
Dawson, Valina L. ;
De laurenzi, Vincenzo ;
De Maria, Ruggero ;
Debatin, Klaus-Michael ;
DeBerardinis, Ralph J. ;
Deshmukh, Mohanish ;
Di Daniele, Nicola ;
Di Virgilio, Francesco ;
Dixit, Vishva M. ;
Dixon, Scott J. .
CELL DEATH AND DIFFERENTIATION, 2018, 25 (03) :486-541
[7]   Approaches to treat immune hot, altered and cold tumours with combination immunotherapies [J].
Galon, Jerome ;
Bruni, Daniela .
NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (03) :197-218
[8]  
Global Cancer Observatory, 2021, CANC TOD
[9]   GSVA: gene set variation analysis for microarray and RNA-Seq data [J].
Haenzelmann, Sonja ;
Castelo, Robert ;
Guinney, Justin .
BMC BIOINFORMATICS, 2013, 14
[10]   Perspectives on Current Tumor-Node-Metastasis (TNM) Staging of Cancers of the Colon and Rectum [J].
Hu, Huankai ;
Krasinskas, Alyssa ;
Willis, Joseph .
SEMINARS IN ONCOLOGY, 2011, 38 (04) :500-510